Sonit Handa, MD, MS, MBA

Sonit Handa, MD, MS, MBA is the Founder and CEO of Biovance Consulting, LLC, a boutique firm dedicated to helping biopharma companies accelerate growth and transformation across the product and enterprise lifecycle, with a focus on rare and specialty medicines.

As a physician, Dr. Handa saw firsthand how the distance between discovery and delivery can define a patient’s outcome. That insight drives Biovance’s mission - to build the systems, teams, and governance that bring life-changing therapies to patients faster, and with precision.

A physician-executive turned architect of organizational systems, Dr. Handa brings over two decades of cross-sector leadership experience spanning biopharma, consulting, and healthcare delivery. He has led global programs uniting Commercial, Medical Affairs, Market Access, Regulatory, and Clinical Development functions to strengthen how therapies move from science to patient impact.

His work spans Global Launch Orchestration, Operational Excellence, and Digital Enablement, including strategic initiatives such as M&A integrations, loss-of-exclusivity (LOE) transitions, outsourcing strategies, and operating-model redesigns that enhance scalability, speed, and cross-functional alignment.

Through his Precision Launch™ Framework and Operational Excellence blueprints, he helps biopharma leaders turn strategy into scalable execution - integrating real-world playbooks, readiness assessments, and AI-enabled dashboards that reduce risk and amplify impact.

Biovance unites Launch Excellence, Medical Affairs Enablement, and Enterprise Transformation under one philosophy:

Every system we design should shorten the path from scientific innovation to patient access.

Working alongside a global network of senior industry experts, Dr. Handa helps biopharma teams deliver results with discipline, clarity, and purpose - because structure can save lives, faster and with precision.